Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72


An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.

Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL.

Oncogene. 2006 Jun 29;25(28):3994-4008. Epub 2006 Feb 20.


Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J.

Breast Cancer Res. 2007;9(1):R16.


Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.

Carmeci C, Thompson DA, Kuang WW, Lightdale N, Furthmayr H, Weigel RJ.

Surgery. 1998 Aug;124(2):211-7.


The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.

Wang Z, Dahiya S, Provencher H, Muir B, Carney E, Coser K, Shioda T, Ma XJ, Sgroi DC.

Clin Cancer Res. 2007 Nov 1;13(21):6327-34.


Differentially expressed genes and estrogen receptor status in breast cancer.

Nagai MA, Ros N, Bessa SA, Mourão Neto M, Miracca EC, Brentani MM.

Int J Oncol. 2003 Nov;23(5):1425-30.


A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

Yu K, Ganesan K, Miller LD, Tan P.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3288-96.


Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schütte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL.

PLoS One. 2008 Aug 20;3(8):e2987. doi: 10.1371/journal.pone.0002987.


Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.

Cancer Res. 2009 Aug 1;69(15):6149-57. doi: 10.1158/0008-5472.CAN-09-1251. Epub 2009 Jul 21.


Challenges in projecting clustering results across gene expression-profiling datasets.

Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.


Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.


Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.

J Clin Oncol. 2006 Apr 10;24(11):1656-64. Epub 2006 Feb 27.


Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C.

BMC Genomics. 2008 May 22;9:239. doi: 10.1186/1471-2164-9-239.


Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.

Scafoglio C, Ambrosino C, Cicatiello L, Altucci L, Ardovino M, Bontempo P, Medici N, Molinari AM, Nebbioso A, Facchiano A, Calogero RA, Elkon R, Menini N, Ponzone R, Biglia N, Sismondi P, De Bortoli M, Weisz A.

J Cell Biochem. 2006 Aug 1;98(5):1163-84.


Molecular characterisation of cell line models for triple-negative breast cancers.

Grigoriadis A, Mackay A, Noel E, Wu PJ, Natrajan R, Frankum J, Reis-Filho JS, Tutt A.

BMC Genomics. 2012 Nov 14;13:619. doi: 10.1186/1471-2164-13-619.


A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17.


Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I.

Endocr Relat Cancer. 2006 Dec;13(4):1109-20.

Items per page

Supplemental Content

Support Center